+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Novozymes AS - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 48 Pages
  • April 2024
  • GlobalData
  • Novozymes Inc
  • ID: 1495434
Novozymes AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - The analyst’s summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

Novozymes AS (Novozymes) is a biotechnology company, which produces and sells industrial enzymes and microorganisms. The company provides enzymes for detergents, and technical, food, and feed industries. It supplies a range of microorganisms for use in agriculture, industrial cleaning, and wastewater treatment; and bio innovation solutions to minimize CO2 emissions. Novozymes’s products also find application in hand and automatic dishwashing soaps, laundry detergents, and professional cleaning products. It also conducts R&D, production, sale, and marketing operations through its subsidiaries. The company has an operational presence spanning Europe, the Middle East, Africa, North America, Asia-Pacific, and Latin America. Novozymes is headquartered in Bagsvaerd, Denmark.

Novozymes AS Key Recent Developments

  • Feb 01, 2024: Legacy Novozymes Delivers Solid Last Full-Year Results
  • Jan 26, 2024: All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen
  • Oct 26, 2023: Novozymes Announces Interim Report for 9M 2023
  • Oct 10, 2023: Executive Leadership Team and Organizational Structure Announced for the Future Combined Company of Novozymes and Chr. Hansen

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with the analyst’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • Novozymes AS - Key Facts
  • Novozymes AS - Key Employees
  • Novozymes AS - Key Employee Biographies
  • Novozymes AS - Major Products and Services
  • Novozymes AS - History
  • Novozymes AS - Company Statement
  • Novozymes AS - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Novozymes AS - Business Description
  • Business Segment: Agriculture, Animal Health & Nutrition
  • Overview
  • Performance
  • Business Segment: Bioenergy
  • Overview
  • Performance
  • Business Segment: Food, Beverages and Human Health
  • Overview
  • Performance
  • Business Segment: Grain and Tech Processing
  • Overview
  • Performance
  • Business Segment: Household Care
  • Overview
  • Performance
  • Geographical Segment: Asia Pacific
  • Performance
  • Geographical Segment: Denmark
  • Performance
  • Geographical Segment: Latin America
  • Performance
  • Geographical Segment: North America
  • Performance
  • Geographical Segment: Rest of Europe, Middle-East and Africa
  • Performance
  • R&D Overview
  • Novozymes AS - Corporate Strategy
  • Novozymes AS - SWOT Analysis
  • SWOT Analysis - Overview
  • Novozymes AS - Strengths
  • Novozymes AS - Weaknesses
  • Novozymes AS - Opportunities
  • Novozymes AS - Threats
  • Novozymes AS - Key Competitors
Section 3 - Company’s Lifesciences, Power Financial Deals and Alliances
  • Novozymes AS, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Novozymes AS, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • Novozymes AS, Recent Deals Summary
Section 4 - Company’s Recent Developments
  • Feb 01, 2024: Legacy Novozymes Delivers Solid Last Full-Year Results
  • Jan 26, 2024: All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen
  • Oct 26, 2023: Novozymes Announces Interim Report for 9M 2023
  • Oct 10, 2023: Executive Leadership Team and Organizational Structure Announced for the Future Combined Company of Novozymes and Chr. Hansen
  • Aug 09, 2023: Novozymes delivers results within expectations in the first half of 2023 and narrows the full year outlook
  • May 22, 2023: Novozymes oneHealth presence felt at 2023 China Gut Conference, featuring the theme, "Innovation, Collaboration, Symbiosis"
  • Mar 30, 2023: Novozymes’ and Chr. Hansen’s shareholders approve combination to create a leading global biosolutions partner
  • Mar 02, 2023: Novozymes Announces Resolutions of Annual Shareholders’ Meeting 2023
  • Feb 03, 2023: Novozymes' Invitation to annual shareholders' meeting 2023
  • Jan 26, 2023: Novozymes delivers historically strong full-year results
Section 5 - Appendix
  • Methodology
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Novozymes AS, Key Facts
  • Novozymes AS, Key Employees
  • Novozymes AS, Key Employee Biographies
  • Novozymes AS, Major Products and Services
  • Novozymes AS, History
  • Novozymes AS, Subsidiaries
  • Novozymes AS, Key Competitors
  • Novozymes AS, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Novozymes AS, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • Novozymes AS, Recent Deals Summary
List of Figures
  • Novozymes AS, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Novozymes AS, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • DSM-Firmenich AG
  • BASF SE
  • FMC Corp
  • Codexis Inc
  • Biocon Ltd
  • Lonza Group Ltd
  • AB Enzymes GmbH
  • DuPont de Nemours Inc
  • Codexis Inc
  • Biocon Ltd
  • Royal DSM NV
  • AB Enzymes GmbH
  • BASF SE